Medical
"Unintended Consequences in Healthcare: When Good Intentions Backfire"
The Law of Unintended Consequences, a concept well-known in various fields, also applies to medicine. It highlights how actions or regulations meant to improve healthcare can sometimes produce the opposite effect, leading to undesired outcomes.
A prime example is the emphasis on pain management in hospitals. Initially, patient surveys revealed that pain was being undertreated, causing distress. This led to increased opioid prescriptions, which, despite aiming to improve patient comfort, inadvertently contributed to the opioid crisis.
Now, healthcare faces another potential unintended consequence related to value-based purchasing programs like the Hospital Consumer Assessment of Healthcare Providers and Systems survey (HCAHPS). While these programs aim to improve care quality and transparency, they may inadvertently encourage practices that compromise patient safety.
Documenting Unintended Effects
Unintended consequences of public-health policies and interventions are reported occasionally, but not systematically. A 2019 review noted that little was known about how these effects arise, whether they fall into categories, or how to evaluate and respond to them. Separately, a study used discharge data from five states to assess how the Affordable Care Act’s Medicaid expansion affected patient-safety outcomes, measured with the PSI 90 composite. The available sources provide no overall statistic for the frequency or scale of unintended consequences.
Anticipating Policy Side Effects
A 2020 analysis warns that initiatives promoting shared decision-making in clinical practice may carry unintended negative consequences if limitations in defining and measuring shared decision-making are not addressed. The World Health Organization article describes approaches to identifying and mitigating adverse effects during policy design and implementation. A 2026 qualitative systematic review examined how factors in the policy process relate to unintended consequences, using a longitudinal lens. Research also discusses how harmful policies may persist even after their negative consequences are recognized.
The CLABSI Conundrum: Are Infection Control Efforts Going Too Far?
The Centers for Medicare and Medicaid Services (CMS) uses the HCAHPS survey to incentivize hospitals to improve care. Hospitals that perform well on quality measures, including those related to infection rates, receive financial rewards. Two key measures are rates of catheter-associated urinary tract infections (CAUTI) and central line-associated bloodstream infections (CLABSI).
- More consistent education to the staff regarding the importance of assuring sterile techniques during the placement and maintenance of central venous access.
- Reducing the duration of central venous access whenever it is used.
- Avoiding it altogether or using an alternative route whenever possible.
Recent Studies of Policy Effects
A study of China’s primary healthcare system examines unintended consequences of the PHI policy through interviews and other perspectives from grassroots healthcare practitioners, using a Grounded Theory approach to explore the mechanisms behind those effects. A 2025 qualitative study focuses on interventions intended to reduce avoidable hospital readmissions. It notes that evaluating these interventions can be complex because unintended consequences may contribute to their failure. These sources address distinct policy settings and do not establish a single general mechanism.
When Competition Policies Have Costs
A 2024 JAMA Health Forum article reports that certificate-of-need (CON) and certificate-of-public-advantage (COPA) laws, together with Affordable Care Act restrictions on physician-owned hospitals (POHs), have been associated with unintended consequences. The reported effects include greater aggregation of market power in larger healthcare facilities, limited access to care, and higher costs for patients. The source describes these outcomes as associated with the laws; it does not provide a quantified estimate in the supplied material.
Opportunities in Healthcare Purchasing
A study focused on improving purchasing performance at UMCG developed a checklist to identify opportunities for improvement in the healthcare purchasing process. Based on a literature review, it identified 38 improvement opportunities. The supplied source describes the checklist and the number of opportunities, but does not provide comparative results against another purchasing process or institution.
Finding the Right Balance: Prioritizing Patient Safety in a Value-Driven World
The drive to reduce CLABSI rates is undoubtedly important, but it should not come at the expense of patient safety. Transferring patients solely to avoid central line placement, or using peripheral lines when central access is clearly indicated, can have detrimental consequences.
Policy Debates and Research Priorities
PwC’s October 2026 outlook examines US healthcare policy changes ahead of the 2026 midterm elections and their implications for providers, pharmaceutical companies, and MedTech strategy. A July 2026 editorial identifies 10 high-priority areas for health services and policy research intended to shape future policy debates and evidence needs. The supplied materials do not name those 10 areas. Together, these sources point to forthcoming policy decisions and research priorities as important topics for the sector.
Learning from Case Studies
A supplied overview of unintended health policy consequences discusses case studies illustrating how policies can lead to unexpected outcomes. It emphasizes the value of historical perspective and stakeholder input in policy development. The source material does not identify the case studies or describe specific affected individuals, so it supports a general point about learning from experience and including stakeholders.
Studies, like the one by Dillon et al., which examine the safety of administering certain solutions peripherally, are crucial. While peripheral infusions can be safe under specific conditions, more research is needed to determine the limits of peripheral administration, especially for potentially caustic substances. Until then, caution and adherence to established protocols are essential.
Value-based purchasing aims to improve healthcare, but constant vigilance is needed to ensure that these incentives do not inadvertently lead to unsafe practices. Open discussions, data analysis, and a commitment to patient-centered care are crucial to navigate these complex challenges and prevent unintended consequences.